ASX:ARX
Aroa Biosurgery Ltd
Location: Australia
ASX
AUD
Common Stock
ISIN: NZARXE0001S1
0%
Response Rate
0 of 3 questions answered
Rate Your
Company Satisfaction
Help us improve
Filter:
SH
Shareholder5 months ago
The company reported cash reserves of NZ$21.6 million but no long-term debt. Are there plans to leverage these cash reserves for expansion or R&D activities?
SH
Shareholder5 months ago
The company anticipates a full-year normalised EBITDA profit of NZ$2-$6 million for FY25. Given the reported NZ$1.5 million EBITDA loss in H1 FY25, what key factors will drive profitability in the second half?
SH
Shareholder5 months ago
Revenue from project fees decreased by 91% from NZ$685,000 in H1 FY24 to NZ$64,000 in H1 FY25. What caused this sharp decline, and how is the company addressing it?